Health Tech Investment Firm, HPCM, Backs Patho Care's Revolutionary Diagnostic Platform

HPCM invests $150.15 million in Patho Care, LLC, reinforcing its commitment to innovative healthcare solutions and significant returns.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here